English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The Covid-19 viral infection is linked to a severe pulmonary reaction, leading to an acute lung injury in a large percentage of affected patients Various inflammatory pathways regulated by SARS-CoV-2 are under-investigated Some potential therapeutic options aimed to alleviate the inflammatory response of SARS-CoV-2 infection are involving different strategies for blocking the activation of its binding receptors on host cells and immunomodulation Given that excessive lung inflammation is likely to cause death in Covid-19 patients, using nitric oxide (NO) pathway to mitigate this risk appears to be a reasonable approach to avoid serious lung injury Such therapy could be paired with systemic immunomodulatory therapy to combat the multiple organ damage of Covid-19 Therefore, regulating the NO pathway has a potential therapeutic strategy to minimize the mortality of SARS-CoV-2 infection © 2020, Romanian Society for Pharmaceutical Sciences All rights reserved

NITRIC OXIDE PATHWAY AS A POTENTIAL THERAPEUTIC TARGET IN COVID-19